Pandemic preparedness: developing vaccines and therapeutic antibodies for COVID-19

dc.creator	Sempowski, Gregory D.
dc.creator	Saunders, Kevin O.
dc.creator	Acharya, Priyamvada
dc.creator	Wiehe, Kevin J.
dc.creator	Haynes, Barton F.
dc.date.accessioned	2020-05-27T13:15:15Z
dc.date.available	2020-05-27T13:15:15Z
dc.date.issued	2020
dc.description.abstract	The SARS-CoV-2 pandemic that causes COVID-19 respiratory syndrome has caused global public health and economic crises necessitating rapid development of vaccines and therapeutic countermeasures. The world-wide response to the COVID-19 pandemic has been unprecedented with government, academic and private partnerships working together to rapidly develop vaccine and antibody countermeasures. Many of the technologies being used are derived from prior government-academic partnerships for response to other emerging infections.	pt_BR
dc.identifier.citation	SEMPOWSKI, G. D. et al. Pandemic preparedness: developing vaccines and therapeutic antibodies for COVID-19. Cell, [S.l.], 2020. No prelo.	pt_BR
dc.identifier.uri	https://repositorio.ufla.br/handle/1/41246
dc.identifier.uri	http://www.sciencedirect.com/science/article/pii/S0092867420306747	pt_BR
dc.language	en_US	pt_BR
dc.publisher	Elsevier	pt_BR
dc.rights	openAccess	pt_BR
dc.source	Cell	pt_BR
dc.subject	COVID-19 - Vaccine	pt_BR
dc.subject	Monoclonal antibodies (mAb)	pt_BR
dc.title	Pandemic preparedness: developing vaccines and therapeutic antibodies for COVID-19	pt_BR
dc.type	Artigo	pt_BR

Arquivos

Agora exibindo 1 - 1 de 1